Cost Segregation Study 58-Year-Old Landlord Nets $186K
A 58-year-old landlord uses a cost segregation study to accelerate depreciation, claiming a $186,000 first-year deduc...
Which Travel Cards Have No Annual Fee
Explore a variety of travel cards that charge no annual fees. Save on costs while maximizing your travel rewards.
26,784 articles
Anthropic Releases First Mythos-Class Model to Public
Anthropic moves to publicly release its first Mythos-class model with Fable 5, while limiting Mythos 5 to partners. T...
Nearly Your Dollars Interest: 2032 Social Security Doomsday
Debt service is eating a growing share of tax receipts, and new projections warn of a 2032 Social Security funding cr...
Intel's Stock Could Push Higher on Underownership, BofA Says
Bank of America highlights Intel's underownership in fund portfolios, suggesting intel’s stock could push higher as o...
Probably Think You’re Really Open to Change? New Insight
A June 2026 study highlights a paradox: many people believe they’re open to new ideas, but true financial resilience ...
What Does Adaptive Biotech Insider Sale Signal for Investors
Insider sales in biotech can spark questions about a company’s future. This guide breaks down what to watch, how to r...
Roku Stock Hits 52-Week High: Is It a Buy Now Today?
Roku stock hits 52-week high has traders buzzing. This article breaks down what’s driving the move, where the risks l...
Industrial Stocks Worth Watching: 2 Names to Watch
Two essential infrastructure players—GE Vernova and Vertiv—sit behind the scenes of AI and modern tech. This guide ex...
Michael Saylor Calls Bitcoin Base Layer for Digital Stack
In a bold reprise of his thesis, Michael Saylor argues Bitcoin is the base layer for a new digital capital stack, pus...
Ethereum's Tech Upgrade Coming: Is It Time to Buy ETH?
As Ethereum gears up for a major tech upgrade, investors wonder if ETH is poised for a move. This guide breaks down w...
Apple’s Incoming Draws Line on AI: Product-First Path
As Apple prepares for a leadership transition, the company emphasizes AI as a tool to strengthen products, not a stan...
Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status